Около

Thus the link between testosterone and aggression and violence is due to these being rewarded with social status. This could explain why some studies find a link between testosterone and pro-social behaviour, if pro-social behaviour is rewarded with social status. Rats who were given anabolic steroids that increase testosterone were also more physically aggressive to provocation as a result of "threat sensitivity". One study found that administering testosterone increased verbal aggression in some participants. The Annals of the New York Academy of Sciences has found that the use of anabolic steroids (which increases testosterone) among teenagers is correlated with increased likelihood of using violence. One study proposed that natural selection may have caused men to be more sensitive to situations in which their status is challenged, and that testosterone is the key factor that causes these situations to spark into aggression. Studies have found higher pre-natal testosterone or lower digit ratio to be correlated with higher aggression.
Testosterone is under development in a low-dose intranasal formulation for the treatment of anorgasmia in women. Testosterone, as esters such as testosterone undecanoate or testosterone buciclate, has been studied and promoted as a male contraceptive analogous to estrogen-based contraceptives in women. Unmodified testosterone was also formerly available for intramuscular injection but was discontinued. Shortly thereafter, in 1937, testosterone first became commercially available as a pharmaceutical drug in the form of pellets and then in ester form for intramuscular injection as the relatively short-acting testosterone propionate. These include oral, buccal, sublingual, intranasal, transdermal (gels, creams, patches), rectal suppositories), by intramuscular or subcutaneous injection (in oil or aqueous), and as a subcutaneous implant.
The process is similar to insulin injection and takes just a few seconds. However, as with all compounded medications, it's important to understand that compounded NAD+ is not FDA-approved. If injection site irritation persists, rotating the injection location or adjusting frequency usually helps.
Therefore, the Food and Drug Administration has recommended that IM administration of testosterone undecanoate be performed slowly by trained personnel in the clinic, and the patient should be observed for at least 30 minutes after injections. IM testosterone therapy was maintained for 3 weeks after enrollment before switching to self-administration of the same dose via the SC route for 8 weeks. As different muscle groups have variable blood flow (eg, the blood flow to the deltoids is higher than the glutei) (44), which further varies with physical activity (45), serum on-treatment testosterone concentrations after IM injections are dependent on these characteristics. B, Schematic illustration of the absorption steps of testosterone esters after intramuscular (left) or subcutaneous (right) injection. Currently, testosterone therapy is indicated for men with unequivocal, organic, or pathologic androgen deficiency to alleviate symptoms and maintain secondary sexual characteristics by raising testosterone into the normal male range (1). Injections with intramuscular (IM) testosterone esters have been available for almost 8 decades and not only result in predictable serum testosterone levels but are also the most inexpensive modality. Agnathans (jawless vertebrates) such as lampreys do not produce testosterone but instead use androstenedione as a male sex hormone.
Sexual arousal and masturbation in women produce small increases in testosterone concentrations. Testosterone levels follow a circadian rhythm that peaks early each day, regardless of sexual activity. Regular monitoring during treatment typically includes hematocrit levels every 3-6 months to prevent polycythemia, along with PSA monitoring in men over 40. Serious side effects may include liver toxicity, heart disease (though a randomized trial found no evidence of major adverse cardiac events compared to placebo in men with low testosterone), and behavioral changes.
The FDA stated in 2015 that neither the benefits nor the safety of testosterone have been established for low testosterone levels due to aging. The reasons cited were limited efficacy (about one additional sexually satisfying event per month), concerns about safety and potential adverse effects with long-term therapy, and concerns about inappropriate off-label use. The United States Food and Drug Administration (FDA) stated in 2015 that neither the benefits nor the safety of testosterone supplement have been established for low testosterone levels due to aging.
The chemical synthesis of testosterone from cholesterol was achieved in August that year by Butenandt and Hanisch. The Organon group in the Netherlands were the first to isolate the hormone, identified in a May 1935 paper "On Crystalline Male Hormone from Testicles (Testosterone)". Suffering the ridicule of his colleagues, he abandoned his work on the mechanisms and effects of androgens in human beings. He reported in The Lancet that his vigor and feeling of well-being were markedly restored but the effects were transient, and Brown-Séquard's hopes for the compound were dashed. A testicular action was linked to circulating blood fractions – now understood to be a family of androgenic hormones – in the early work on castration and testicular transplantation in fowl by Arnold Adolph Berthold (1803–1861). Testosterone has been detected at variably higher and lower levels among men of various nations and from various backgrounds, explanations for the causes of this have been relatively diverse. Testosterone's bioavailable concentration is commonly determined using the Vermeulen calculation or more precisely using the modified Vermeulen method, which considers the dimeric form of sex hormone-binding globulin.
They named the hormone testosterone, from the stems of testicle and sterol, and the suffix of ketone. Several professional medical groups have recommended that 350 ng/dL generally be considered the minimum normal level, which is consistent with previous findings.non-primary source neededmedical citation needed Levels of testosterone in men decline with age. Approximately 5 to 7% of testosterone is converted by 5α-reductase into 5α-DHT, with circulating levels of 5α-DHT about 10% of those of testosterone, and approximately 0.3% of testosterone is converted into estradiol by aromatase.